Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. announced interim results from its Phase 1 clinical trial at the 2024 Visceral Medicine Congress in Leipzig, Germany. The study evaluates the safety and efficacy …
Panavance Unveils Game-Changing Data: A New Hope for Pancreatic Cancer Patients? Read More BERWYN, PA — Panavance Therapeutics Inc. has announced the publication of encouraging data on misetionamide in the peer-reviewed journal, Cancer Medicine. The study conducted by Kim et al. at MD …
Panavance Therapeutics Reports Positive Data on Misetionamide in Ovarian Cancer Read More BERWYN, PA — Chester County-based biotech company, Panavance Therapeutics Inc., has announced the recent publication of positive data in the International Journal of Molecular Sciences about the anti-tumor activity of …
Panavance Therapeutics’ Cancer Drug Misetionamide Shows Promising Results in Melanoma Treatment Read More